Our Senior Trial Manager, Doris Lanz, is representing the ICR-CTSU at the #ABSConference2024 . You can find our stand on our ABS #ClinicalTrials just outside the main hall. If you are attending, please come and chat about our #BreastCancer #ClinicalTrials . ABS

Thank you to Prof. David Huntsman from University of British Columbia for joining us today to give a fascinating talk about his research on the role of cell context, mutations and microenvironment in #OvarianCancer control.

We're looking for a Biostatistician/Data Scientist to join our team. If you're interested, you can find out more and apply here: tinyurl.com/2s37nmym. Applications close on 2nd June 2024. #StatsJobs #DataScienceJobs

The POUT #ClinicalTrial , investigating post-surgery chemotherapy for upper tract #UrothelialCancer , has a new webpage including a plain English summary of the results. You can read the summary, results and find out more information here: icr.ac.uk/our-research/c…

Laura Moretti ICR-CTSU talks about the PlasmaMATCH trial and considers the impact the design had on all aspects of the trial lifecycle including working with participants sites.

#UKCTUNetwork #CTUTrialMgrsMay24

A great pleasure contributing to this precision medicine course with James Wason Haiyan Zheng to a very engaged audience. Thanks Haiyan Zheng for the excellent organisation of the course & workshop!

Thank you to Dr J. Jack Lee, who visited us this week from the MD Anderson Cancer Center Department of Biostatistics, University of Texas, to hold an seminar on 'Bayesian Adaptive Design for Every Clinical Trialist'.

Everything you wanted to know about thr POUT trial but were after to ask Brian Rini, MD 💙alison birtle Tom Powles podcasters.spotify.com/pod/show/the-u…